0.71 -0.02 (-2.74%)

53.59% Fall from 52W High

869.1K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Seres Therapeutics Inc

The latest disclosure was made by Teresa L. Young in Seres Therapeutics Inc where a trade of 2,657 Restricted Stock Units done was reported to US exchanges on Feb. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,657 21,250 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 8,907 26,718 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,657 137,849 (0%) 0% - Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 8,907 146,756 (0%) 0% - Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 0.81 per share. 15 Feb 2025 4,300 142,456 (0%) 0% 0.8 3,485 Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,657 21,250 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 26,563 79,687 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 178,202 (0%) 0% - Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 26,563 204,765 (0%) 0% - Common Stock
Eric D. Shaff Director, CEO and President Sale of securities on an exchange or to another person at price $ 0.81 per share. 15 Feb 2025 12,726 192,039 (0%) 0% 0.8 10,314 Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 62,500 - - Restricted Stock Units
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 88,396 (0%) 0% - Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 23,437 - - Restricted Stock Units
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 0.81 per share. 15 Feb 2025 3,953 84,443 (0%) 0% 0.8 3,204 Common Stock
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 0.81 per share. 15 Feb 2025 3,338 97,536 (0%) 0% 0.8 2,704 Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 100,874 (0%) 0% - Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,657 93,061 (0%) 0% - Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 7,813 23,437 - - Restricted Stock Units
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 8,907 26,718 - - Restricted Stock Units
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 0.81 per share. 15 Feb 2025 4,416 39,875 (0%) 0% 0.8 3,579 Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 8,907 44,291 (0%) 0% - Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,969 35,384 (0%) 0% - Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,969 23,750 - - Restricted Stock Units
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,813 80,583 (0%) 0% - Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2025 2,813 22,500 - - Restricted Stock Units
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 650,000 650,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 650,000 650,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 650,000 650,000 - - Stock Option (Right to Buy)
Eric D. Shaff Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 1,950,000 1,950,000 - - Stock Option (Right to Buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 650,000 650,000 - - Stock Option (Right to Buy)
Hans-Juergen Woerle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2025 120,000 120,000 - - Stock Option (right to buy)
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,969 33,392 (0%) 0% - Common Stock
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 0.54 per share. 15 Nov 2024 735 90,404 (0%) 0% 0.5 398 Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,656 91,139 (0%) 0% - Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,656 23,907 - - Restricted Stock Units
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,969 26,719 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,656 136,070 (0%) 0% - Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,656 23,907 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 0.54 per share. 15 Nov 2024 878 135,192 (0%) 0% 0.5 475 Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 7,812 172,894 (0%) 0% - Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 7,812 70,313 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Sale of securities on an exchange or to another person at price $ 0.54 per share. 15 Nov 2024 2,505 170,389 (0%) 0% 0.5 1,355 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,812 25,313 - - Restricted Stock Units
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2024 2,812 78,697 (0%) 0% - Common Stock
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 0.54 per share. 15 Nov 2024 927 77,770 (0%) 0% 0.5 501 Common Stock
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 0.54 per share. 15 Nov 2024 977 32,415 (0%) 0% 0.5 528 Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 13,744 0 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 13,500 0 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 13,500 137,673 (0%) 0% 0 Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 0.69 per share. 27 Oct 2024 4,259 133,414 (0%) 0% 0.7 2,939 Common Stock
Eric D. Shaff Director, CEO and President Sale of securities on an exchange or to another person at price $ 0.69 per share. 27 Oct 2024 8,748 165,082 (0%) 0% 0.7 6,037 Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 27,837 0 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 27,837 173,830 (0%) 0% 0 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 12,622 0 - - Restricted Stock Units
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 0.69 per share. 27 Oct 2024 3,984 75,885 (0%) 0% 0.7 2,749 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 12,622 79,869 (0%) 0% 0 Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 13,744 34,757 (0%) 0% 0 Common Stock
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 0.69 per share. 27 Oct 2024 4,334 30,423 (0%) 0% 0.7 2,991 Common Stock
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 0.69 per share. 27 Oct 2024 2,983 88,483 (0%) 0% 0.7 2,059 Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 11,360 0 - - Restricted Stock Units
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2024 11,360 91,466 (0%) 0% 0 Common Stock
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 973 21,013 (0%) 0% 0.8 817 Common Stock
David S. Ege See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,969 78,703 (0%) 0% - Common Stock
David S. Ege See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,969 29,688 - - Restricted Stock Units
David S. Ege See Remarks Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 1,128 77,575 (0%) 0% 0.8 948 Common Stock
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 728 80,106 (0%) 0% 0.8 612 Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,656 80,834 (0%) 0% - Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,656 26,563 - - Restricted Stock Units
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,969 21,986 (0%) 0% - Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,969 29,688 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,656 125,046 (0%) 0% - Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,656 26,563 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 873 124,173 (0%) 0% 0.8 733 Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 7,813 148,511 (0%) 0% - Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 7,813 78,125 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 2,518 145,993 (0%) 0% 0.8 2,115 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,813 28,125 - - Restricted Stock Units
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 2,813 68,170 (0%) 0% - Common Stock
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 0.84 per share. 15 Aug 2024 923 67,247 (0%) 0% 0.8 775 Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2024 85,000 0 - - Restricted Stock Units
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2024 85,000 102,658 (0%) 0% - Common Stock
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 1.08 per share. 03 Aug 2024 24,480 78,178 (0%) 0% 1.1 26,534 Common Stock
Kurt C. Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 64,564 64,564 - - Stock Option (right to buy)
Dennis A. Ausiello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 64,564 64,564 - - Stock Option (right to buy)
Stephen Berenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 114,782 114,782 - - Stock Option (Right to Buy)
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,656 123,233 (0%) 0% - Common Stock
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,656 29,219 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 0.94 per share. 15 May 2024 843 122,390 (0%) 0% 0.9 792 Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 7,812 143,133 (0%) 0% - Common Stock
Eric D. Shaff Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 7,812 85,938 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Sale of securities on an exchange or to another person at price $ 0.94 per share. 15 May 2024 2,435 140,698 (0%) 0% 0.9 2,289 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,812 66,248 (0%) 0% - Common Stock
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 0.94 per share. 15 May 2024 891 65,357 (0%) 0% 0.9 838 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,812 30,938 - - Restricted Stock Units
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,656 18,361 (0%) 0% - Common Stock
Teresa L. Young See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,656 29,219 - - Restricted Stock Units
Teresa L. Young See Remarks Sale of securities on an exchange or to another person at price $ 0.94 per share. 15 May 2024 703 17,658 (0%) 0% 0.9 661 Common Stock
David S. Ege See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,968 76,824 (0%) 0% - Common Stock
David S. Ege See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2024 2,968 32,657 - - Restricted Stock Units
David S. Ege See Remarks Sale of securities on an exchange or to another person at price $ 0.94 per share. 15 May 2024 1,090 75,734 (0%) 0% 0.9 1,025 Common Stock
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2024 2,968 32,657 - - Restricted Stock Units
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2024 2,968 19,956 (0%) 0% - Common Stock
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 0.94 per share. 14 May 2024 939 19,017 (0%) 0% 0.9 883 Common Stock
Kurt C. Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (right to buy)
Willard H. Dere Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (right to buy)
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (right to buy)
Dennis A. Ausiello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (right to buy)
Paul R. Biondi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (Right to Buy)
Stephen Berenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2024 60,000 60,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 4,400 16,988 (0%) 0% 1.1 4,752 Common Stock
J. DesRosier Thomas Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
Thomas DesRosier J. Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 31,875 - - Restricted Stock Units
A. Arkowitz David Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
von Moltke Lisa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 213,750 213,750 - - Stock Option (Right to Buy)
Eric Shaff D. Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 637,500 637,500 - - Stock Option (Right to Buy)
von Moltke Lisa See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,875 35,625 - - Restricted Stock Units
Eric Shaff D. Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 31,250 146,870 (0%) 0% - Common Stock
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
J. Thomas DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 124,516 (0%) 0% - Common Stock
L. Young Teresa See Remarks Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 3,374 15,705 (0%) 0% 1.1 3,644 Common Stock
J. Thomas DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 35,625 35,625 - - Restricted Stock Units
S. David Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 31,250 31,250 - - Restricted Stock Units
Shaff Eric D. Director, CEO and President Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 11,549 135,321 (0%) 0% 1.1 12,473 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,250 33,750 - - Restricted Stock Units
L. Young Teresa See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 31,875 - - Restricted Stock Units
Ege David S. See Remarks Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 5,010 73,856 (0%) 0% 1.1 5,411 Common Stock
von Moltke Lisa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 35,625 35,625 - - Restricted Stock Units
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 31,250 31,250 - - Restricted Stock Units
Ege S. David See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
S. Ege David See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 187,500 187,500 - - Stock Option (Right to Buy)
J. Thomas DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 213,750 213,750 - - Stock Option (Right to Buy)
Henn Matthew See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,250 67,606 (0%) 0% - Common Stock
S. David Ege See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,875 78,866 (0%) 0% - Common Stock
David Arkowitz A. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 31,875 - - Restricted Stock Units
Lisa von Moltke See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,875 21,388 (0%) 0% - Common Stock
Henn Matthew See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 187,500 187,500 - - Stock Option (Right to Buy)
L. Teresa Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 287,905 287,905 - - Stock Option (Right to Buy)
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 35,625 35,625 - - Restricted Stock Units
Ege David S. See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 11,875 35,625 - - Restricted Stock Units
L. Young Teresa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 187,500 187,500 - - Stock Option (Right to Buy)
Arkowitz A. David Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 3,939 182,442 (0%) 0% 1.1 4,254 Common Stock
Shaff D. Eric Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 822,580 822,580 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 4,170 63,436 (0%) 0% 1.1 4,504 Common Stock
L. Young Teresa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 31,250 31,250 - - Restricted Stock Units
David Arkowitz A. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 186,381 (0%) 0% - Common Stock
Shaff D. Eric Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 31,250 93,750 - - Restricted Stock Units
J. DesRosier Thomas Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 1.08 per share. 14 Feb 2024 3,939 120,577 (0%) 0% 1.1 4,254 Common Stock
Arkowitz David A. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 213,750 213,750 - - Stock Option (Right to Buy)
D. Shaff Eric Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 106,250 106,250 - - Restricted Stock Units
Young Teresa L. See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 10,625 19,079 (0%) 0% - Common Stock
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2023 42,500 166,613 (0%) 0% 0 Common stock
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2023 35,000 70,000 - - Stock Option (Right to Buy)
David S. Ege See Remarks Sale of securities on an exchange or to another person at price $ 5.19 per share. 27 Apr 2023 7,038 59,696 (0%) 0% 5.2 36,527 Common stock
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2023 20,000 66,734 (0%) 0% 0 Common stock
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 42,500 42,500 - - Restricted Stock Units
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 85,000 85,000 - - Stock Option (Right to Buy)
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 85,000 85,000 - - Stock Option (Right to Buy)
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 42,500 42,500 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 125,000 125,000 - - Restricted Stock Units
Eric D. Shaff Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 250,000 250,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 90,000 90,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 45,000 45,000 - - Restricted Stock Units
Paula Cloghessy See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 47,500 47,500 - - Restricted Stock Units
Paula Cloghessy See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 95,000 95,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 95,000 95,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 47,500 47,500 - - Restricted Stock Units
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 85,000 85,000 - - Stock Option (Right to Buy)
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 85,000 85,000 - - Restricted Stock Units
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 42,500 42,500 - - Restricted Stock Units
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 95,000 95,000 - - Stock Option (Right to Buy)
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 47,500 47,500 - - Restricted Stock Units
David S. Ege See Remarks Sale of securities on an exchange or to another person at price $ 7.93 per share. 27 Oct 2022 5,012 46,734 (0%) 0% 7.9 39,745 Common stock
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Oct 2022 20,000 51,746 (0%) 0% 0 Common stock
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2022 35,000 35,000 - - Stock Option (Right to Buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 63,492 104,546 (0%) 0% 3.2 200,000 COMMON STOCK
Willard H. Dere Director Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 31,746 31,746 (0%) 0% 3.2 100,000 COMMON STOCK
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 63,492 65,492 (0%) 0% 3.2 200,000 COMMON STOCK
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 63,492 63,492 (0%) 0% 3.2 200,000 COMMON STOCK
Eric D. Shaff Director, CEO and President Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 63,492 96,334 (0%) 0% 3.2 200,000 COMMON STOCK
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 47,619 47,619 (0%) 0% 3.2 150,000 COMMON STOCK
Paul R. Biondi Director Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 47,619 47,619 (0%) 0% 3.2 150,000 COMMON STOCK
Paula Cloghessy See Remarks Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 31,746 31,746 (0%) 0% 3.2 100,000 COMMON STOCK
Meryl S. Zausner Director Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 31,746 31,746 (0%) 0% 3.2 100,000 COMMON STOCK
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 3.15 per share. 05 Jul 2022 31,746 31,746 (0%) 0% 3.2 100,000 COMMON STOCK
Kurt C. Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Kurt C. Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Willard H. Dere Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Dennis A. Ausiello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Paul R. Biondi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Meryl S. Zausner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Meryl S. Zausner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Stephen Berenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
David A. Arkowitz Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2022 5,000 0 - - Restricted Stock Units
David A. Arkowitz Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2022 5,000 70,492 (0%) 0% 0 Common stock
David A. Arkowitz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 42,500 112,992 (0%) 0% 0 Common stock
Paula Cloghessy See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 190,000 190,000 - - Stock Options (right to buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 130,000 130,000 - - Stock Option (Right to Buy)
David A. Arkowitz See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 190,000 190,000 - - Stock Option (Right to Buy)
Eric D. Shaff Director, President, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 500,000 500,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 175,000 175,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 175,000 175,000 - - Stock Option (Right to Buy)
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 120,000 120,000 - - Stock Option (Right to Buy)
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 175,000 175,000 - - Stock Option (Right to Buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 100,000 100,000 - - Stock Option (Right to Buy)
Eric D. Shaff Director, President, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 350,000 350,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 130,000 130,000 - - Stock Option (Right to Buy)
Marcus Chapman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 12,000 12,000 - - Restricted Stock Units
Marcus Chapman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 24,000 24,000 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 110,000 110,000 - - Stock Option (Right to Buy)
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2021 90,000 90,000 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 01 Dec 2020 26,000 38,000 (0%) 0% 0.7 18,460 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 27,562 45,938 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 26,250 3,750 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 26,000 0 - - Stock Option (Right to Buy)
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 28.34 per share. 01 Dec 2020 9,841 0 (0%) 0% 28.3 278,894 Common Stock
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 27.56 per share. 01 Dec 2020 26,265 9,841 (0%) 0% 27.6 723,863 Common Stock
Matthew Henn See Remarks Sale of securities on an exchange or to another person at price $ 26.56 per share. 01 Dec 2020 55,706 36,106 (0%) 0% 26.6 1,479,551 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.01 per share. 01 Dec 2020 27,562 91,812 (0%) 0% 6.0 165,648 Common Stock
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.89 per share. 01 Dec 2020 26,250 64,250 (0%) 0% 9.9 259,613 Common Stock
Stephen Berenson Director Other type of transaction at price $ 0.00 per share. 23 Nov 2020 3,589 3,589 (0%) 0% 0 Common Stock
David S. Ege See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2020 200,000 200,000 - - Stock Option (Right to Buy)
Teresa L. Young See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2020 300,000 300,000 - - Stock Option (Right to Buy)
Kurt C. Graves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Willard H. Dere Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Dennis A. Ausiello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Paul Biondi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Meryl Zausner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Stephen Berenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Marcus Chapman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2020 18,596 18,596 - - STOCK OPTION (RIGHT TO BUY)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2020 325,000 325,000 - - Stock Option (Right to Buy)
Paul Biondi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 30,000 30,000 - - Stock Option (Right to Buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 350,000 350,000 - - STOCK OPTION (RIGHT TO BUY)
John G. Aunins Chief Technology Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 300,000 300,000 - - STOCK OPTION (RIGHT TO BUY)
Eric D. Shaff President CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 1,000,000 1,000,000 - - STOCK OPTION (RIGHT TO BUY)
Matthew Henn See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 300,000 300,000 - - STOCK OPTION (RIGHT TO BUY)
Marcus Chapman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2020 125,000 125,000 - - STOCK OPTION (RIGHT TO BUY)
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 25,000 0 - - RESTRICTED STOCK UNITS
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 25,000 41,054 (0%) 0% - COMMON STOCK
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 12,500 0 - - RESTRICTED STOCK UNITS
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 12,500 105,250 (0%) 0% - COMMON STOCK
Eric D. Shaff CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 20,000 32,842 (0%) 0% - COMMON STOCK
Eric D. Shaff CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 20,000 0 - - RESTRICTED STOCK UNITS
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 7,500 0 - - RESTRICTED STOCK UNITS
Matthew Henn See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2020 7,500 12,000 (0%) 0% - COMMON STOCK
Marcus Chapman See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2019 12,000 0 - - Restricted Stock Units
Marcus Chapman See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2019 12,000 12,000 (0%) 0% 0 Common Stock
Marcus Chapman See Remarks Sale of securities on an exchange or to another person at price $ 3.91 per share. 01 Nov 2019 3,400 8,600 (0%) 0% 3.9 13,297 Common Stock
Stephen Berenson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2019 30,000 30,000 - - Stock Option (Right to Buy)
Noubar B. Afeyan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.25 per share. 18 Jun 2019 4,444,444 4,444,444 (6%) 6% 2.3 9,999,999 Common Stock
Noubar B. Afeyan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.25 per share. 18 Jun 2019 4,444,444 4,444,444 (6%) 6% 2.3 9,999,999 Common Stock
Kurt C. Graves None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Willard H. Dere None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Richard N. Kender None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Dennis A. Ausiello None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Roger J. Pomerantz None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Gregory Behar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Lorence H. Kim None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
Meryl Zausner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2019 15,000 15,000 - - Stock Option (right to buy)
David N. Cook See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2019 7,500 147,435 (0%) 0% - COMMON STOCK
David N. Cook See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2019 7,500 12,500 - - RESTRICTED STOCK UNITS
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 84,800 84,800 - - STOCK OPTION (RIGHT TO BUY)
Thomas J. DesRosier Chief Legal Officer and EVP Sale of securities on an exchange or to another person at price $ 5.75 per share. 25 Jan 2019 5,471 16,054 (0%) 0% 5.8 31,478 COMMON STOCK
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 15,000 21,525 (0%) 0% - COMMON STOCK
Thomas J. DesRosier Chief Legal Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 15,000 25,000 - - RESTRICTED STOCK UNITS
Kevin Horgan Chief Medical Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 30,000 30,000 - - STOCK OPTION (RIGHT TO BUY)
John G. Aunins Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 7,500 12,500 - - RESTRICTED STOCK UNITS
John G. Aunins Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 60,000 60,000 - - STOCK OPTION (RIGHT TO BUY)
John G. Aunins Chief Technology Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 7,500 92,750 (0%) 0% - COMMON STOCK
Eric D. Shaff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 12,000 20,000 - - RESTRICTED STOCK UNITS
Eric D. Shaff See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 275,000 275,000 - - STOCK OPTION (RIGHT TO BUY)
Eric D. Shaff See Remarks Sale of securities on an exchange or to another person at price $ 5.75 per share. 25 Jan 2019 4,378 12,842 (0%) 0% 5.8 25,188 COMMON STOCK
Eric D. Shaff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2019 12,000 17,220 (0%) 0% - COMMON STOCK
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2018 10,000 85,250 (0%) 0% 0 COMMON STOCK
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 6.39 per share. 17 Dec 2018 14,282 75,250 (0%) 0% 6.4 91,313 COMMON STOCK
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Dec 2018 10,000 0 - - RESTRICTED STOCK UNITS
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 8.26 per share. 15 Nov 2018 14,279 89,532 (0%) 0% 8.3 117,912 COMMON STOCK
Kevin Horgan Chief Medical Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2018 225,000 225,000 - - Stock Option (right to buy)
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 5.94 per share. 15 Oct 2018 14,279 103,811 (0%) 0% 5.9 84,800 COMMON STOCK
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.00 per share. 07 Sep 2018 1,810 213,976 (0%) 0% 9.0 16,291 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.04 per share. 05 Sep 2018 3,013 215,786 (0%) 0% 9.0 27,235 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.12 per share. 05 Sep 2018 9,505 218,799 (0%) 0% 9.1 86,714 Common Stock
Meryl Zausner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Aug 2018 30,000 30,000 - - Stock Option (right to buy)
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 8.10 per share. 16 Jul 2018 14,279 160,927 (0%) 0% 8.1 115,726 COMMON STOCK
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.01 per share. 11 Jul 2018 1,010 228,304 (0%) 0% 9.0 9,099 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 11 Jul 2018 1,010 229,314 (0%) 0% 0.7 717 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jul 2018 1,010 797,536 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.05 per share. 06 Jul 2018 5,989 228,304 (0%) 0% 9.1 54,208 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2018 10,981 804,535 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2018 15,366 815,516 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jul 2018 5,989 798,546 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 06 Jul 2018 5,989 234,293 (0%) 0% 0.7 4,252 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.14 per share. 06 Jul 2018 10,981 228,304 (0%) 0% 9.1 100,351 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 06 Jul 2018 10,981 239,285 (0%) 0% 0.7 7,797 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.14 per share. 06 Jul 2018 15,366 228,304 (0%) 0% 9.1 140,507 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 06 Jul 2018 15,366 243,670 (0%) 0% 0.7 10,910 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.10 per share. 28 Jun 2018 4,496 228,304 (0%) 0% 9.1 40,915 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.15 per share. 28 Jun 2018 21,560 228,304 (0%) 0% 9.2 197,375 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 28 Jun 2018 21,560 249,864 (0%) 0% 0.7 15,308 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 21,560 835,378 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2018 4,496 830,882 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 28 Jun 2018 4,496 232,800 (0%) 0% 0.7 3,192 Common Stock
Kurt C. Graves None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Willard H. Dere None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Richard N. Kender None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Dennis A. Ausiello None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Gregory Behar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Lorence H. Kim None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2018 15,000 15,000 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2018 16,991 856,938 - - STOCK OPTION(RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2018 16,288 895,153 - - STOCK OPTION(RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jun 2018 21,224 873,929 - - STOCK OPTION(RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 25 Jun 2018 16,288 255,056 (0%) 0% 0.7 11,564 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.21 per share. 25 Jun 2018 26,752 228,304 (0%) 0% 9.2 246,504 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 25 Jun 2018 21,224 249,528 (0%) 0% 0.7 15,069 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.19 per share. 25 Jun 2018 21,224 228,304 (0%) 0% 9.2 195,133 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 25 Jun 2018 16,991 245,295 (0%) 0% 0.7 12,064 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.03 per share. 25 Jun 2018 16,991 228,304 (0%) 0% 9.0 153,408 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.33 per share. 20 Jun 2018 26,492 297,812 (0%) 0% 9.3 247,051 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.36 per share. 20 Jun 2018 40,057 238,768 (0%) 0% 9.4 374,761 Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.06 per share. 20 Jun 2018 18,987 278,825 (0%) 0% 9.1 172,094 Common Stock
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 5,000 10,000 - - RESTRICTED STOCK UNITS
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 5,000 175,206 (0%) 0% 0 COMMON STOCK
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 8.57 per share. 15 Jun 2018 14,279 170,206 (0%) 0% 8.6 122,325 Common Stock
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 7.27 per share. 15 May 2018 14,279 118,090 (0%) 0% 7.3 103,875 COMMON STOCK
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 8.08 per share. 15 May 2018 14,279 146,648 (0%) 0% 8.1 115,400 COMMON STOCK
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 7.57 per share. 15 May 2018 14,279 132,369 (0%) 0% 7.6 108,069 COMMON STOCK
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 9.00 per share. 09 May 2018 233 324,304 (0%) 0% 9 2,097 Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 7.58 per share. 25 Apr 2018 14,279 184,485 (0%) 0% 7.6 108,266 Common Stock
Roger J. Pomerantz Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2018 278,000 278,000 - - Stock Option (right to buy)
David N. Cook See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 75,000 75,000 - - STOCK OPTION (RIGHT TO BUY)
David N. Cook See Remarks Sale of securities on an exchange or to another person at price $ 11.02 per share. 26 Jan 2018 1,738 139,935 (0%) 0% 11.0 19,153 COMMON STOCK
David N. Cook See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 5,000 141,673 (0%) 0% 0 COMMON STOCK
David N. Cook See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 5,000 20,000 - - RESTRICTED STOCK UNITS
Thomas J. DesRosier See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 80,000 80,000 - - STOCK OPTION (RIGHT TO BUY)
Thomas J. DesRosier See Remarks Sale of securities on an exchange or to another person at price $ 11.02 per share. 26 Jan 2018 3,475 6,525 (0%) 0% 11.0 38,295 COMMON STOCK
Thomas J. DesRosier See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 10,000 10,000 (0%) 0% 0 COMMON STOCK
Thomas J. DesRosier See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 100,000 100,000 - - STOCK OPTION (RIGHT TO BUY)
Thomas J. DesRosier See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 10,000 40,000 - - RESTRICTED STOCK UNITS
Michele Trucksis See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 7,500 30,000 - - RESTRICTED STOCK UNITS
Michele Trucksis See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 95,000 95,000 - - STOCK OPTION (RIGHT TO BUY)
Michele Trucksis See Remarks Sale of securities on an exchange or to another person at price $ 11.02 per share. 26 Jan 2018 2,607 4,893 (0%) 0% 11.0 28,729 COMMON STOCK
Michele Trucksis See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 7,500 7,500 (0%) 0% 0 COMMON STOCK
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 11.02 per share. 26 Jan 2018 1,738 198,764 (0%) 0% 11.0 19,153 COMMON STOCK
John G. Aunins See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 40,000 40,000 - - STOCK OPTION (RIGHT TO BUY)
John G. Aunins See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 5,000 20,000 - - RESTRICTED STOCK UNITS
John G. Aunins See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 5,000 200,502 (0%) 0% 0 COMMON STOCK
Eric D. Shaff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 8,000 8,000 (0%) 0% 0 COMMON STOCK
Eric D. Shaff See Remarks Sale of securities on an exchange or to another person at price $ 11.02 per share. 26 Jan 2018 2,780 5,220 (0%) 0% 11.0 30,636 COMMON STOCK
Eric D. Shaff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2018 8,000 32,000 - - RESTRICTED STOCK UNITS
Eric D. Shaff See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2018 120,000 120,000 - - STOCK OPTION (RIGHT TO BUY)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jan 2018 40,241 911,441 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 24 Jan 2018 40,241 324,537 (0%) 0% 0.7 28,571 Common Stock
John G. Aunins See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2017 5,000 197,125 (0%) 0% 0 COMMON STOCK
John G. Aunins See Remarks Sale of securities on an exchange or to another person at price $ 10.14 per share. 19 Dec 2017 1,623 195,502 (0%) 0% 10.1 16,457 COMMON STOCK
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. 18 Jul 2017 100,604 284,296 (0%) 0% 0.7 71,429 Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2017 100,604 951,682 - - Stock Option (right to buy)
Willard H. Dere None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 30,000 30,000 - - Stock Option (right to buy)
Kurt C. Graves None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Richard N. Kender None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Dennis A. Ausiello None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Gregory Behar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Lorence H. Kim None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
John G. Aunins Chief Technology Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2017 20,000 20,000 - - Restricted Stock Units
David N. Cook Chief Scientific Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 25,000 25,000 - - Restricted Stock Units
David N. Cook Chief Scientific Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 75,000 75,000 - - Stock Option (right to buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 60,000 60,000 - - Stock Option (right to buy)
Thomas J. DesRosier Chief Legal Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 50,000 50,000 - - Restricted Stock Units
Roger J. Pomerantz Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 261,000 261,000 - - Stock Option (right to buy)
Michele Trucksis Chief Medical Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 100,000 100,000 - - Stock Option (right to buy)
Michele Trucksis Chief Medical Officer and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 37,500 37,500 - - Restricted Stock Units
John G. Aunins Chief Technology Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 25,000 25,000 - - Restricted Stock Units
John G. Aunins Chief Technology Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 50,000 50,000 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 105,000 105,000 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 40,000 40,000 - - Restricted Stock Units
Wael Hashad EVP & Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 25,000 25,000 - - Restricted Stock Units
Wael Hashad EVP & Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2017 75,000 75,000 - - Stock Option (right to buy)
John G. Aunins Chief Technology Officer & EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2016 30,000 30,000 - - Stock Option (right to buy)
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Aug 2016 9,390 192,125 - - Common Stock
Michele Trucksis Chief Medical Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jul 2016 4,156 296,904 - - Stock Option (Right to Buy)
Michele Trucksis Chief Medical Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jul 2016 4,156 4,156 - - Common Stock
Michele Trucksis Chief Medical Officer and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Jul 2016 4,156 0 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2016 20,000 1,052,286 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2016 20,000 203,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jul 2016 20,000 183,692 - - Common Stock
Michele Trucksis Chief Medical Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2016 38,064 301,060 - - Stock Option (Right to Buy)
Michele Trucksis Chief Medical Officer and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jul 2016 38,064 38,064 - - Common Stock
Michele Trucksis Chief Medical Officer and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jul 2016 38,064 0 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jul 2016 9,250 201,515 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jul 2016 187,500 12,500 - - Stock Option(right to buy)
John G. Aunins Chief Technology Officer & EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jul 2016 187,500 220,155 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Jul 2016 9,390 210,765 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2016 52,776 1,107,718 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2016 35,435 1,072,283 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2016 52,776 236,468 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jul 2016 49,871 186,597 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jul 2016 2,905 183,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jul 2016 35,435 219,127 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jul 2016 9,900 209,227 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jul 2016 25,535 183,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2016 56,789 1,160,497 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2016 56,789 240,481 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2016 4,832 235,649 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2016 41,957 193,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2016 10,000 183,692 - - Common Stock
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2016 4,533 233,454 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2016 4,533 4,533 - - Common Stock
Eric D. Shaff CFO and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jun 2016 4,533 0 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jun 2016 9,390 32,655 - - Common Stock
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2016 3,334 239,654 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2016 1,667 237,987 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2016 3,334 3,334 - - Common Stock
Eric D. Shaff CFO and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jun 2016 3,334 0 - - Common Stock
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2016 1,667 1,667 - - Common Stock
Eric D. Shaff CFO and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jun 2016 1,667 0 - - Common Stock
Noubar B. Afeyan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
Peter Barton Hutt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
Dennis A. Ausiello None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
Richard N. Kender None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
Kurt C. Graves None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
Lorence H. Kim None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2016 15,000 15,000 - - Stock Option (right to buy)
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jun 2016 8,000 136,673 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2016 74,049 1,217,286 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2016 74,049 257,741 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jun 2016 6,583 251,158 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jun 2016 47,159 203,999 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jun 2016 20,307 183,692 - - Common Stock
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jun 2016 16,000 144,673 - - Common Stock
Thomas J. DesRosier See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2016 100,000 100,000 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2016 70,951 1,291,335 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2016 70,951 254,643 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jun 2016 18,510 236,133 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jun 2016 52,441 183,692 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 May 2016 13,365 42,695 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 May 2016 650 42,045 - - Common Stock
Noubar B. Afeyan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 May 2016 320,562 2,734,994 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 May 2016 80,141 1,925,462 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 May 2016 599,297 0 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 25 May 2016 800,000 8,022,420 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 25 May 2016 200,000 1,925,462 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 25 May 2016 33,507 33,514 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 25 May 2016 7 33,514 - - Common Stock, $0.001 par value
Noubar B. Afeyan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 25 May 2016 33,514 0 - - Common Stock, $0.001 par value
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2016 9,801 1,362,286 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 May 2016 9,801 193,493 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 May 2016 9,801 183,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2016 160,965 1,372,087 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2016 160,965 183,692 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 29,298 1,571,586 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 30,027 1,541,559 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 28,598 51,325 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2016 28,598 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 700 23,427 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2016 700 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 21,127 43,854 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2016 21,127 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2016 8,900 31,627 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2016 8,900 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2016 43,687 1,624,564 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2016 23,680 1,600,884 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2016 43,687 66,414 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2016 35,438 30,976 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2016 8,249 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2016 23,680 46,407 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2016 16,338 30,069 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2016 7,142 22,927 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 May 2016 200 22,727 - - Common Stock
John G. Aunins Chief Technology Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Apr 2016 18,640 56,060 - - Common Stock
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Apr 2016 8,000 160,673 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2016 1,712 82,500 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2016 7,500 1,668,251 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2016 1,712 24,439 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2016 7,500 31,939 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Apr 2016 9,212 22,727 - - Common Stock
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2016 6,568 242,988 - - Stock Option (right to buy)
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2016 6,568 6,568 - - Common Stock
Eric D. Shaff CFO and EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Apr 2016 6,568 0 - - Common Stock
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 46,650 183,023 - - Common Stock
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 6,350 176,673 - - Common Stock
David N. Cook Chief Scientific Officer & EVP Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 8,000 168,673 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2016 90,963 129,037 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2016 44,825 84,212 - - Stock Option (right to buy)
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2016 90,963 113,690 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 40,506 73,184 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 38,080 35,104 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 12,377 22,727 - - Common Stock
Roger J. Pomerantz Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2016 44,825 67,552 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 15,203 52,349 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 22,418 29,931 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 6,416 23,515 - - Common Stock
Roger J. Pomerantz Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2016 788 22,727 - - Common Stock
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2016 7,663 249,556 - - Stock Option(right to buy)
Eric D. Shaff CFO and EVP Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2016 7,663 7,663 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures